The goal of this cross-sectional study is to learn if the GeneXpert system is a practical system for HIV and STBBI testing in community-based organizations and health clinics. The study involves a clinical trial to learn if the HIV-1 Qual XC test works to identify HIV in near-patient settings. The main questions it aims to answer are to create a near-patient testing model for testing and treating patients in a single visit, and to learn if the HIV-1 Qual XC test works to accurately detect HIV in patients. Patients who come to study sites to ask for HIV or STBBI testing will be given the option to participate in the study. Those who agree with provide samples for the tests of their choice and answer survey questions before and after their tests are completed. Those who participate in the clinical trial will have a blood sample sent to provincial labs to compare the results to the HIV -1 Qual XC test. Follow-up visits will be done at 1,3 and 6 months to see if patients completed treatment and/or remained connected to care.
Inclusion Criteria:
Exclusion Criteria:
Sean.Rourke@unityhealth.to416-878-2779
Participants will screen with Health Canada approved rapid antibody tests for HIV, syphillis and/or HCV. Screen results may impact which GeneXpert test that participants can receive.
Megan.Cedrone@unityhealth.to(647)-786-8711
Xpert Ultra and Xpert HIV-VL in People Living With HIV
Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons
GeneXpert Performance Evaluation for Linkage to Tuberculosis Care
Ayaangwaamiziwin Initiative: Carefulness and Preparedness
Point of Care Rapid STI Test Optimization and Validation Extension
The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa
Multiplo Near Patient Non-HCP Study
Triage Test for All Oral DR-TB Regimen (TRiAD Study)